EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulation of FOXO3 Transcriptional Regulation by Cisplatin and Curcumin in Human Embryonic Kidney Cells

Edson Coronado-Moreno iD, Victor Mendoza-Santos iD, Isabel Larre iD, Diana González-Cázares iD, Elisa Dorantes iD, Oscar Medina-Contreras iD, Adriana Sánchez-Boiso, Benjamin A Rodriguez-Espino iD, Omar Guadarrama iD, Mara Medeiros iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27208970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Edson Coronado-Moreno und 9 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, National Autonomous University of Mexico, Mexico City 04510, Mexico. Hauptthemen laut MEDLINE: Cisplatin, Curcumin, Forkhead Box Protein O3, Antineoplastic Agents. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Infantil de México Federico Gómez.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin is a highly effective anti-neoplastic agent, but its clinical application is limited by its association with severe nephrotoxicity. Although extensive research has identified several mechanisms underlying cisplatin-induced nephrotoxicity, the precise molecular pathways remain incompletely understood. Recent studies have highlighted the role of intrinsic survival, senescence, and longevity signaling pathways, including those governed by the FOXO3 transcription factor. In this study, we examined the effects of cisplatin and curcumin on the DNA methylation status and mRNA expression of FOXO3 in human embryonic kidney (HEK293) cells. Our results indicate that the FOXO3 promoter is methylated in cisplatin-treated cells, and that cisplatin regulates FOXO3 transcription in a dose-dependent manner. Quantitative RT-qPCR revealed that moderate cytotoxic concentrations of cisplatin (10 and 40 µM) significantly downregulate FOXO3 mRNA. Furthermore, co-treatment with the antioxidant curcumin successfully restored and enhanced FOXO3 expression at moderate cisplatin doses (10 µM) but failed to rescue expression at high doses (40 µM). Moreover, curcumin treatment (10 µM) reverses the effects of low-dose, but not high-dose, cisplatin (40 and 60 µM). Taken together, these findings provide a foundation for understanding the epigenetic and transcriptional regulation of FOXO3 and highlight its potential as a target for antioxidant-mediated nephroprotection and its role in cell survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinCurcuminForkhead Box Protein O3Antineoplastic AgentsGene Expression RegulationKidneyTranscription, GeneticHumansDNA MethylationHEK293 CellsPromoter Regions, GeneticCell Survival

Stichwörter der Autor:innen

FOXO3cisplatincurcuminepigeneticsnephrotoxicityrenal damage

Substanzen

CisplatinCurcuminForkhead Box Protein O3FOXO3 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Facultad de Medicina, National Autonomous University of Mexico, Mexico City 04510, Mexico.
  • Unidad de Investigación y Diagnóstico en Nefrología y Metabolismo Mineral Óseo, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
  • Biobanco de Células, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
  • Laboratorio de Inmunometabolismo, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
  • Dirección de Investigación, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.

ORCID-Profile: Edson Coronado-Moreno, Victor Mendoza-Santos, Isabel Larre, Diana González-Cázares, Elisa Dorantes, Oscar Medina-Contreras, Benjamin A Rodriguez-Espino, Omar Guadarrama, Mara Medeiros

Förderung

  • Hospital Infantil de México Federico Gómez

Zitieren

APA

Coronado-Moreno, E., Mendoza-Santos, V., Larre, I., González-Cázares, D., Dorantes, E., Medina-Contreras, O., Sánchez-Boiso, A., Rodriguez-Espino, B. A., Guadarrama, O., & Medeiros, M. (2026). Modulation of FOXO3 Transcriptional Regulation by Cisplatin and Curcumin in Human Embryonic Kidney Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27208970

Vancouver

Coronado-Moreno E, Mendoza-Santos V, Larre I, González-Cázares D, Dorantes E, Medina-Contreras O, et al. Modulation of FOXO3 Transcriptional Regulation by Cisplatin and Curcumin in Human Embryonic Kidney Cells. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27208970

BibTeX
@article{CoronadoMoreno2026,
  author = {Coronado-Moreno, Edson and Mendoza-Santos, Victor and Larre, Isabel and González-Cázares, Diana and Dorantes, Elisa and Medina-Contreras, Oscar and Sánchez-Boiso, Adriana and Rodriguez-Espino, Benjamin A and Guadarrama, Omar and Medeiros, Mara},
  title = {Modulation of FOXO3 Transcriptional Regulation by Cisplatin and Curcumin in Human Embryonic Kidney Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27208970}
}
Kostenlos starten →